Cite
A surrogate cell‐based SARS‐CoV‐2 spike blocking assay.
MLA
Schuh, Wolfgang, et al. “A Surrogate Cell‐based SARS‐CoV‐2 Spike Blocking Assay.” European Journal of Immunology, vol. 51, no. 11, Nov. 2021, pp. 2665–76. EBSCOhost, https://doi.org/10.1002/eji.202149302.
APA
Schuh, W., Baus, L., Steinmetz, T., Schulz, S. R., Weckwerth, L., Roth, E., Hauke, M., Krause, S., Morhart, P., Rauh, M., Hoffmann, M., Vesper, N., Reth, M., Schneider, H., Jäck, H., & Mielenz, D. (2021). A surrogate cell‐based SARS‐CoV‐2 spike blocking assay. European Journal of Immunology, 51(11), 2665–2676. https://doi.org/10.1002/eji.202149302
Chicago
Schuh, Wolfgang, Lena Baus, Tobit Steinmetz, Sebastian R. Schulz, Leonie Weckwerth, Edith Roth, Manuela Hauke, et al. 2021. “A Surrogate Cell‐based SARS‐CoV‐2 Spike Blocking Assay.” European Journal of Immunology 51 (11): 2665–76. doi:10.1002/eji.202149302.